Neuropace Stock Forecast - Price Action Indicator
| NPCE Stock | USD 15.95 0.28 1.73% |
Neuropace Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Neuropace stock prices and determine the direction of Neuropace's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Neuropace's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The relative strength index (RSI) of Neuropace's share price is at 54. This indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Neuropace, making its price go up or down. Momentum 54
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.19) | EPS Estimate Current Year (0.74) | EPS Estimate Next Year (0.64) | Wall Street Target Price 19.25 | EPS Estimate Current Quarter (0.19) |
Using Neuropace hype-based prediction, you can estimate the value of Neuropace from the perspective of Neuropace response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Neuropace using Neuropace's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Neuropace using crowd psychology based on the activity and movement of Neuropace's stock price.
Neuropace Short Interest
A significant increase or decrease in Neuropace's short interest from the previous month could be a good indicator of investor sentiment towards Neuropace. Short interest can provide insight into the potential direction of Neuropace stock and how bullish or bearish investors feel about the market overall.
200 Day MA 12.0976 | Short Percent 0.0436 | Short Ratio 4.19 | Shares Short Prior Month 936.6 K | 50 Day MA 15.8184 |
Neuropace Relative Strength Index
Neuropace Hype to Price Pattern
Investor biases related to Neuropace's public news can be used to forecast risks associated with an investment in Neuropace. The trend in average sentiment can be used to explain how an investor holding Neuropace can time the market purely based on public headlines and social activities around Neuropace. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Neuropace's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Neuropace.
Neuropace Implied Volatility | 1.42 |
Neuropace's implied volatility exposes the market's sentiment of Neuropace stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Neuropace's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Neuropace stock will not fluctuate a lot when Neuropace's options are near their expiration.
Neuropace after-hype prediction price | USD 15.95 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Neuropace | Build AI portfolio with Neuropace Stock |
Prediction based on Rule 16 of the current Neuropace contract
Based on the Rule 16, the options market is currently suggesting that Neuropace will have an average daily up or down price movement of about 0.0888% per day over the life of the 2026-03-20 option contract. With Neuropace trading at USD 15.95, that is roughly USD 0.0142 . If you think that the market is fully incorporating Neuropace's daily price movement you should consider acquiring Neuropace options at the current volatility level of 1.42%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Neuropace Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Neuropace's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Neuropace's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Neuropace stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Neuropace's open interest, investors have to compare it to Neuropace's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Neuropace is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Neuropace. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Neuropace Additional Predictive Modules
Most predictive techniques to examine Neuropace price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neuropace using various technical indicators. When you analyze Neuropace charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.37) | (0.39) |
| Check Neuropace Volatility | Backtest Neuropace | Information Ratio |
Neuropace Trading Date Momentum
| On January 27 2026 Neuropace was traded for 15.95 at the closing time. The top price for the day was 16.52 and the lowest listed price was 15.88 . The trading volume for the day was 119.2 K. The trading history from January 27, 2026 did not cause price change. The trading delta at closing time against the current closing price is 1.63% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Neuropace to competition |
Other Forecasting Options for Neuropace
For every potential investor in Neuropace, whether a beginner or expert, Neuropace's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Neuropace Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Neuropace. Basic forecasting techniques help filter out the noise by identifying Neuropace's price trends.Neuropace Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neuropace stock to make a market-neutral strategy. Peer analysis of Neuropace could also be used in its relative valuation, which is a method of valuing Neuropace by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Neuropace Market Strength Events
Market strength indicators help investors to evaluate how Neuropace stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neuropace shares will generate the highest return on investment. By undertsting and applying Neuropace stock market strength indicators, traders can identify Neuropace entry and exit signals to maximize returns.
| Accumulation Distribution | 4619.31 | |||
| Daily Balance Of Power | (0.44) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 16.2 | |||
| Day Typical Price | 16.12 | |||
| Price Action Indicator | (0.39) | |||
| Period Momentum Indicator | (0.28) | |||
| Relative Strength Index | 54.67 |
Neuropace Risk Indicators
The analysis of Neuropace's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neuropace's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neuropace stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.01 | |||
| Semi Deviation | 2.16 | |||
| Standard Deviation | 5.67 | |||
| Variance | 32.09 | |||
| Downside Variance | 6.91 | |||
| Semi Variance | 4.67 | |||
| Expected Short fall | (3.83) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Neuropace
The number of cover stories for Neuropace depends on current market conditions and Neuropace's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Neuropace is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Neuropace's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Neuropace Short Properties
Neuropace's future price predictability will typically decrease when Neuropace's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Neuropace often depends not only on the future outlook of the potential Neuropace's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neuropace's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 29.1 M | |
| Cash And Short Term Investments | 52.8 M |
Check out Historical Fundamental Analysis of Neuropace to cross-verify your projections. For information on how to trade Neuropace Stock refer to our How to Trade Neuropace Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuropace. If investors know Neuropace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuropace listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.75) | Revenue Per Share | Quarterly Revenue Growth 0.299 | Return On Assets | Return On Equity |
The market value of Neuropace is measured differently than its book value, which is the value of Neuropace that is recorded on the company's balance sheet. Investors also form their own opinion of Neuropace's value that differs from its market value or its book value, called intrinsic value, which is Neuropace's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuropace's market value can be influenced by many factors that don't directly affect Neuropace's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuropace's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuropace is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuropace's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.